The MAPS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with targeted therapy plus immunotherapy.

Jingzhong OuyangYi YangYanzhao ZhouFeng YeZhengzheng WangQingjun LiYing XuLu LiXinming ZhaoWen ZhangAiping ZhouZhen HuangYong WangJianqiang CaiHong ZhaoJinxue Zhou

Published in: Hepatology international (2023)

The MAPS-CRAFITY score based on sarcopenia and the CRAFITY score is a reliable and practical tool for predicting the efficacy of targeted therapy plus immunotherapy in patients with unresectable HCC, and may help hepatologists and oncologists in clinical decision-making.

Keyphrases

decision making
locally advanced
liver metastases
skeletal muscle
squamous cell carcinoma
radiation therapy